Cystoscopy: Clinical Trials

14 trials of Cystoscopy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 2 active not recruiting, 2 completed, 1 not yet recruiting. 14 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Recruiting 6, Active not recruiting 2, Completed 2, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 15Recruiting 3, Completed 1, Not yet recruiting 1
Phase 31Recruiting 1

Follow Cystoscopy: new trials by email Literature Review of Cystoscopy trials Research Report on Cystoscopy

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma
BCG Solution, Best Practice, Cystoscopy - Non-Muscle Invasive Bladder Carcinoma
Phase 1 / Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center492027-01-152026-10-14
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Radiosensitizing Agent - Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8
Phase 1 / Phase 2RecruitingUniversity of Washington122026-08-202026-08-25
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Biospecimen Collection, Computed Tomography, Cystoscopy - Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)1112025-11-252026-11-03
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
BCG Solution, Cystoscopy, Docetaxel - Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic402025-04-212026-10-08
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Enfortumab Vedotin, Pembrolizumab, Intensity Modulated Radiation Therapy (IMRT) - Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Phase 1 / Phase 2RecruitingUniversity of California, San Francisco472025-03-312026-10-01
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Biospecimen Collection, cfDNA or ctDNA Measurement, Computed Tomography - Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2 / Phase 3RecruitingNational Cancer Institute (NCI)9922024-02-022026-11-12
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test - Non-muscle-invasive Bladder Cancer
Phase 2RecruitingWhite River Junction Veterans Affairs Medical Center2402023-11-172026-09-16
Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial
Atezolizumab, Biospecimen Collection, Computed Tomography - Bladder Carcinoma, Bladder Urothelial Carcinoma
Phase 2WithdrawnNational Cancer Institute (NCI)2023-10-122025-10-21
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
Biopsy of Bladder, Biospecimen Collection, Cisplatin - Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8
Phase 2Active not recruitingNational Cancer Institute (NCI)112021-03-172026-05-22
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Bladder Flat Urothelial Carcinoma In Situ, Non-Muscle Invasive Bladder Urothelial Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)1612020-03-182026-11-12
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Durvalumab, Cystoscopy with Biopsy - Carcinoma in Situ of Bladder, Bladder Cancer
Phase 2TerminatedH. Lee Moffitt Cancer Center and Research Institute172017-02-162022-07-29
Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions
intratrigonal injection of botulinum toxin, cystoscopy - Interstitial Cystitis
Phase 2UnknownMoscow State University of Medicine and Dentistry602011-06-012011-09-21
Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer
cisplatin, gemcitabine hydrochloride, biopsy - Bladder Cancer
Phase 1 / Phase 2CompletedInstitut du Cancer de Montpellier - Val d'Aurelle142005-06-012015-07-30
Interstitial Cystitis
H&P; ECG; Blood tests; voiding diary; Cystoscopy - Interstitial Cystitis
Phase 2CompletedICOS Corporation1502003-01-012005-06-24

Conditions studied

Urinary Bladder Neoplasms (9)  ·  Non-Muscle Invasive Bladder Neoplasms (3)  ·  Cystitis, Interstitial (2)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Transitional Cell (1)  ·  Neoplasms (1)  ·  Urinary Bladder Diseases (1)

Sponsors

National Cancer Institute (NCI) (5)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  ICOS Corporation (1)  ·  Institut du Cancer de Montpellier - Val d'Aurelle (1)  ·  Mayo Clinic (1)  ·  Moscow State University of Medicine and Dentistry (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of California, San Francisco (1)  ·  University of Washington (1)  ·  White River Junction Veterans Affairs Medical Center (1)

Countries

United States (11)  ·  Canada (1)  ·  France (1)  ·  Guam (1)  ·  Puerto Rico (1)  ·  Russia (1)

Top investigators

Cheryl T Lee, MD (1)  ·  David Azria, MD, PhD (1)  ·  Di Maria Jiang (1)  ·  Florian R Schroeck, MD, MS (1)  ·  Jingsong Zhang, M.D., Ph.D. (1)  ·  Leslie Ballas (1)  ·  Lyn Frumkin, M.D., Ph.D. (1)  ·  Matthew D Galsky (1)  ·  Michael E Woods (1)  ·  Monika Joshi (1)  ·  T. Martin Ma, MD, PhD (1)  ·  Timothy D. Lyon, MD (1)  ·  Vadim Koshkin, MD (1)

Results publications

PMID 32734597

NIH funding

U10CA180821 (2), R37CA275916 (1), U10CA180820 (1), U10CA180888 (1), UL1TR002377 (1), UM1CA186644 (1)